Cyclooxygenase inhibitors: a novel direction for Alzheimer's management.

Journal Title: Pharmacological Reports - Year 2008, Vol 60, Issue 5

Abstract

Research in Alzheimer's disease (AD) currently includes various cellular, molecular, genetic, clinical and therapeutic approaches. The cytopathological significance of oxidative damage has been studied in neurons of AD patients. Many epidemiological studies suggest that use of non-steroidal anti-inflammatory drugs (NSAIDs) delay or slow the clinical expression of AD, and anti-oxidant properties of NSAIDs have also been previously described. Therefore, in this study we examined the role of various cyclooxygenase (COX)-1 and COX-2 inhibitors (NSAIDs) in a rat model of aluminum-induced oxidative stress to mimic AD-like conditions. We found that the animals receiving aluminum treatment for one month (4.2 mg/kg, ip) had highly elevated levels of reactive oxygen species (expressed as malondialdehyde - MDA). Moreover, treatment with the COX-2 inhibitor, rofecoxib (0.83 mg/kg, po), was able to significantly reduce this oxidative stress (p < 0.05 when compared to aluminum treatment alone on MDA levels). But, nonspecific COX inhibitors (flurbiprofen, 0.83 mg/kg twice a day po and ibuprofen, 100 mg/kg, po), did not protect again oxidative stress. Thus, in agreement with earlier epidemiological studies, we propose that COX-2 specific NSAIDs may be beneficial in AD management. Further experimental work towards identifying the most efficacious COX-2 inhibitors, as well as the mechanism of action and the optimal dosage regimen should be executed.

Authors and Affiliations

Manish Nivsarkar, Aryamitra Banerjee, Harish Padh

Keywords

Related Articles

Are anti-inflammatory properties of lipoic acid associated with the formation of hydrogen sulfide?

Lipoic acid (LA) was shown to possess anti-inflammatory properties. In this study, we present evidence supporting the hypothesis that the anti-inflammatory properties of LA are associated with the formation of hydrogen s...

The future of traditional nonsteroidal antiinflammatory drugs and cyclooxygenase-2 inhibitors in the treatment of inflammation and pain.

Prostanoids act leading roles in a myriad of physiologic and pathologic processes because these autacoids participate in the amplification of biological responses induced by innumerable stimuli. The formation of prostano...

Dose-response relationship analysis of vigabatrin doses and their antinociceptive effects in the hot-plate test in mice.

This study was aimed at determining the analgesic effects of vigabatrin (VGB, a newer antiepileptic drug) in the acute thermal pain model (hot-plate test) in mice. Linear regression analysis was used to evaluate a dose-r...

Vane's blood-bathed organ technique adapted to examine the endothelial effects of cardiovascular drugs in vivo.

This study describes a modification of Vane's blood-bathed organ technique (BBOT). This new technique consisted of replacing the cascade of contractile smooth muscle organs within the traditional BBOT by a single collage...

Impact of ABCB1 (MDR1) gene polymorphism and P-glycoprotein inhibitors on digoxin serum concentration in congestive heart failure patients.

Digoxin, a drug of narrow therapeutic index, is a substrate for common transmembrane transporter, P-glycoprotein, encoded by ABCB1 (MDR1) gene. It has been suggested that ABCB1 polymorphism, as well as co-administration...

Download PDF file
  • EP ID EP82939
  • DOI -
  • Views 102
  • Downloads 0

How To Cite

Manish Nivsarkar, Aryamitra Banerjee, Harish Padh (2008). Cyclooxygenase inhibitors: a novel direction for Alzheimer's management.. Pharmacological Reports, 60(5), 692-698. https://europub.co.uk/articles/-A-82939